Mesenchymal stem cells (MSCs), as an undifferentiated group of adult multipotent cells,
have remarkable antitumor features that bring them up as a novel choice to treat cancers …

Cellular carriers for drug delivery are attractive alternatives to synthetic nanoparticles owing
to their innate homing/targeting abilities. Here, we review molecular interactions involved in …

A series of hydrogels based on chitosan polyamine and nitrosalicylaldehyde were prepared
via dynamic covalent chemistry (DCC), by imination and transimination reactions towards …

Recent studies have demonstrated that culture under hypoxia has beneficial effects on
mesenchymal stem cells (MSCs). However, there are limitations to achieving a stable …

Abstract Background and Objective Increasing interest has developed in the therapeutic
potential of bone marrow-derived mesenchymal stem cells (MSCs) for the treatment of …

Although a lot of research has been performed, large segmental bone defects caused by
trauma, infection, bone tumors or revision surgeries still represent big challenges for trauma …

Cardiovascular diseases (CVDs), including a series of pathological disorders, severely
affect millions of people all over the world. To address this issue, several potential therapies …

Mesenchymal stem cell (MSC) transplantation is regarded as a promising candidate for the
treatment of ischaemic heart disease. The major hurdles for successful clinical translation of …

Over the past 2 decades, therapies based on mesenchymal stem cells (MSC) have been
tested to treat several types of diseases in clinical studies, due to their potential for tissue …

Ischemic diseases refer to a wide range of diseases caused by reduced blood flow and a
subsequently deficient oxygen and nutrient supply. The pathogenesis of ischemia is …